Perceived risk following melanoma genetic testing: A 2-year prospective study distinguishing subjective estimates from recall

Lisa G. Aspinwall, Jennifer M. Taber, Wendy Kohlmann, Samantha L. Leaf, Sancy Leachman

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

A major goal of predictive genetic testing is to alert people to their risk before illness onset; however, little is known about how risk perceptions change following genetic testing and whether information is recalled accurately over time. In the United States, a CDKN2A/p16 mutation confers 76 % lifetime risk of melanoma. Following genetic counseling and test reporting, subjective risk estimates and recall of counselor-provided risk estimates were assessed 5 times over the next 2 years among 60 adult members of 2 extended CDKN2A/p16 kindreds. No sustained changes from baseline in risk perceptions were reported. Unaffected carriers (n=15) consistently reported significantly lower subjective risk estimates (46 %) than they were actually given (76 %, p

Original languageEnglish (US)
Pages (from-to)421-437
Number of pages17
JournalJournal of Genetic Counseling
Volume23
Issue number3
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Genetic Testing
varespladib methyl
Melanoma
Prospective Studies
Genetic Counseling
Mutation

Keywords

  • CDKN2A/p16
  • Genetic counseling
  • Genetic testing
  • Melanoma
  • Perceived risk

ASJC Scopus subject areas

  • Genetics(clinical)
  • Medicine(all)

Cite this

Perceived risk following melanoma genetic testing : A 2-year prospective study distinguishing subjective estimates from recall. / Aspinwall, Lisa G.; Taber, Jennifer M.; Kohlmann, Wendy; Leaf, Samantha L.; Leachman, Sancy.

In: Journal of Genetic Counseling, Vol. 23, No. 3, 2014, p. 421-437.

Research output: Contribution to journalArticle

Aspinwall, Lisa G. ; Taber, Jennifer M. ; Kohlmann, Wendy ; Leaf, Samantha L. ; Leachman, Sancy. / Perceived risk following melanoma genetic testing : A 2-year prospective study distinguishing subjective estimates from recall. In: Journal of Genetic Counseling. 2014 ; Vol. 23, No. 3. pp. 421-437.
@article{9de53866fb3a4c34a5f286b49569dbb3,
title = "Perceived risk following melanoma genetic testing: A 2-year prospective study distinguishing subjective estimates from recall",
abstract = "A major goal of predictive genetic testing is to alert people to their risk before illness onset; however, little is known about how risk perceptions change following genetic testing and whether information is recalled accurately over time. In the United States, a CDKN2A/p16 mutation confers 76 {\%} lifetime risk of melanoma. Following genetic counseling and test reporting, subjective risk estimates and recall of counselor-provided risk estimates were assessed 5 times over the next 2 years among 60 adult members of 2 extended CDKN2A/p16 kindreds. No sustained changes from baseline in risk perceptions were reported. Unaffected carriers (n=15) consistently reported significantly lower subjective risk estimates (46 {\%}) than they were actually given (76 {\%}, p",
keywords = "CDKN2A/p16, Genetic counseling, Genetic testing, Melanoma, Perceived risk",
author = "Aspinwall, {Lisa G.} and Taber, {Jennifer M.} and Wendy Kohlmann and Leaf, {Samantha L.} and Sancy Leachman",
year = "2014",
doi = "10.1007/s10897-013-9676-1",
language = "English (US)",
volume = "23",
pages = "421--437",
journal = "Journal of Genetic Counseling",
issn = "1059-7700",
publisher = "Kluwer Academic/Human Sciences Press Inc.",
number = "3",

}

TY - JOUR

T1 - Perceived risk following melanoma genetic testing

T2 - A 2-year prospective study distinguishing subjective estimates from recall

AU - Aspinwall, Lisa G.

AU - Taber, Jennifer M.

AU - Kohlmann, Wendy

AU - Leaf, Samantha L.

AU - Leachman, Sancy

PY - 2014

Y1 - 2014

N2 - A major goal of predictive genetic testing is to alert people to their risk before illness onset; however, little is known about how risk perceptions change following genetic testing and whether information is recalled accurately over time. In the United States, a CDKN2A/p16 mutation confers 76 % lifetime risk of melanoma. Following genetic counseling and test reporting, subjective risk estimates and recall of counselor-provided risk estimates were assessed 5 times over the next 2 years among 60 adult members of 2 extended CDKN2A/p16 kindreds. No sustained changes from baseline in risk perceptions were reported. Unaffected carriers (n=15) consistently reported significantly lower subjective risk estimates (46 %) than they were actually given (76 %, p

AB - A major goal of predictive genetic testing is to alert people to their risk before illness onset; however, little is known about how risk perceptions change following genetic testing and whether information is recalled accurately over time. In the United States, a CDKN2A/p16 mutation confers 76 % lifetime risk of melanoma. Following genetic counseling and test reporting, subjective risk estimates and recall of counselor-provided risk estimates were assessed 5 times over the next 2 years among 60 adult members of 2 extended CDKN2A/p16 kindreds. No sustained changes from baseline in risk perceptions were reported. Unaffected carriers (n=15) consistently reported significantly lower subjective risk estimates (46 %) than they were actually given (76 %, p

KW - CDKN2A/p16

KW - Genetic counseling

KW - Genetic testing

KW - Melanoma

KW - Perceived risk

UR - http://www.scopus.com/inward/record.url?scp=84901944400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901944400&partnerID=8YFLogxK

U2 - 10.1007/s10897-013-9676-1

DO - 10.1007/s10897-013-9676-1

M3 - Article

C2 - 24322567

AN - SCOPUS:84901944400

VL - 23

SP - 421

EP - 437

JO - Journal of Genetic Counseling

JF - Journal of Genetic Counseling

SN - 1059-7700

IS - 3

ER -